Comparative In Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive Cocci
Open Access
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (3) , 802-805
- https://doi.org/10.1128/aac.44.3.802-805.2000
Abstract
The in vitro activity of gemifloxacin against 316 bloodstream isolates of staphylococci, pneumococci, and enterococci was compared with the activities of six fluoroquinolones and three other antimicrobial agents. Of the antimicrobial agents tested, gemifloxacin was the most potent against penicillin-intermediate and -resistant pneumococci, methicillin-susceptible and -resistant Staphylococcus epidermidis isolates, and coagulase-negative staphylococci.Keywords
This publication has 10 references indexed in Scilit:
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- A Cross-Canada Surveillance of Antimicrobial Resistance in Respiratory Tract PathogensCanadian Journal of Infectious Diseases, 1999
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- VANCOMYCIN-RESISTANT ENTEROCOCCI: Mechanism and Clinical RelevanceInfectious Disease Clinics of North America, 1997
- ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCIInfectious Disease Clinics of North America, 1997
- Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995.1997
- Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridoneAntimicrobial Agents and Chemotherapy, 1997
- Emergence and nosocomial transmission of ampicillin-resistant enterococciAntimicrobial Agents and Chemotherapy, 1992